Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

Motor ActivityAttention DeficitStress, Psychological

Interventions

OTHER

microencapsulated Glycine

100 mg microencapsulated Glycine (Bidicin® from Biotiki® ) t.i.d.

OTHER

Placebo tablets

Placebo t.i.d. from Biotiki® in a crossover-design.

Trial Locations (1)

University Hospital, Freiburg im Breisgau